You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
佛慈制藥(002644.SZ)取得換髮《藥品生產許可證》
格隆匯 02-08 16:13

格隆匯 2 月 8日丨佛慈制藥(002644.SZ)公佈,公司原《藥品生產許可證》即將到期,近日,公司收到甘肅省藥品監督管理局換髮的《藥品生產許可證》,現將有關情況公吿如下:

企業名稱:蘭州佛慈制藥股份有限公司;許可證編號:甘20160093;企業信用代碼:91620000712762468N;分類碼:AhzyCz;註冊地址:甘肅省蘭州市蘭州新區華山路2289號;法定代表人:石愛國;企業負責人:尚壽鵬;質量負責人:柴國林;生產地址和生產範圍:蘭州新區華山路2289號:片劑、硬膠囊劑、顆粒劑(含中藥配方顆粒)、散劑、丸劑(濃縮丸、濃縮水丸、濃縮蜜丸、水丸、小蜜丸、大蜜丸、水蜜丸、濃縮水蜜丸、糊丸)、合劑、糖漿劑、酒劑、茶劑、煎膏劑、膏劑、口服液,前處理、提取、甘肅省平涼市公路街18號:片劑、硬膠囊劑、顆粒劑、散劑、丸劑(大蜜丸、濃縮丸、水丸、水蜜丸)、茶劑、膠劑,前處理、提取,中藥飲片(含毒性飲片);有效期至:2026年01月31日。

此次換髮《藥品生產許可證》是原證即將到期,新證的取得確保了公司的正常生產經營。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account